World Journal of Pharmaceutical
Science and Research

A Global Platform for Open Access, Peer-Reviewed, and Indexed Research in the
Pharmaceutical and Medical Sciences



ISSN: 2583-6579


IF: 6.916



Submit Article

ABSTRACT

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF RELUGOLIX IN BULK AND TABLET DOSAGE FORM

Pritam S. Jain*, Ashish P. Gorle*, N. G. Haswani, Savita Mandan, Hina Chaudhari, Mayuri Chaudhari

A new simple, precise, accurate, sensitive and rapid chromatographic method based on RP-HPLC was developed and validated for the estimation of Relugolix in bulk and tablet dosage form. Methanol: Water (70:30 v/v)) was used as mobile phase. A isocratic programing has been done, on a reverse phase Qualisil C18, (250 mm× 4.6mm, 5 μm) with rate 0.8 mL/min, monitored at 290 nm. The mean retention times of Relugolix were found to be 4.10 min respectively. Linearity of Relugolix was found to be 2-12 μg/mL, R2= 0.9993 respectively. The developed methods have shown the best findings in terms of linearity, accuracy, precision, LOD and LOQ for API and in tablet. The depicted method can routinely be used for the determination of Relugolix in bulk and tablet formulation.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our 2026 IMPACT FACTOR has increased from 5.111 to 6.916

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    June 2026 Issue Now Available

    June 2026 Issue is now available online for readers and contributors. Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Upcoming Issue (2026)

    The journal invites researchers, academicians, and scholars to submit their original research articles, review papers, and case studies for the upcoming July 2026 Issue . All submissions will undergo a standard peer-review process.